Computing Zagreb and Randić Indices of PEG-Cored Dendrimers Used for Drug and Gene Delivery

Jude, Thayamathy Pio; Elango, P.; Koneswaran, Masilamani

doi:10.1155/2020/2821510

Cited by 2 publications

(1 citation statement)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The dark-field images similarly exhibit hyper-intense signals (C) . Furthermore, both diffusion-weighted images and apparent diffusion coefficient ( 5 ) images do not indicate any restrictions in diffusion (D, E) .…”

Section: Case Reportmentioning

confidence: 99%

A Chinese patient with POLR3A-related leukodystrophy: a case report and literature review

Sun,

Lin,

Meng

et al. 2023

Front. Neurol.

View full text Add to dashboard Cite

BackgroundLeukodystrophies are hereditary white matter diseases characterized by genetic polymorphisms and considerable phenotypic variability. They can be classified into myelin and non-myelin malformations. These diseases are rare, affecting 1 out of 250,000–500,000 individuals and can manifest at any age. A subtype of leukodystrophy, associated with missense mutations in the RNA polymerase subunit III (POLR3A) gene, is inherited in an autosomal recessive manner.Case reportWe report and analyse a case of a 34-year-old female who presented with ataxia. Magnetic Resonance Imaging (MRI) of the brain revealed demyelinating lesions in the white matter. Genetic testing identified the c.4044C > G and c.1186-2A > G variants in the POLR3A gene. The patient was diagnosed with hypomyelinating leukodystrophy type 7 and received neurotrophic and symptomatic supportive therapy. However, after 1 month of follow-up, there was no improvement in her symptoms.ConclusionPOLR3A-induced leukodystrophy is relatively rare and not well understood, making it challenging to diagnose and easy to overlook. The prognosis for this disease is generally poor, significantly impacting the quality of life of affected individuals. Currently, no cure is available for this condition, and treatment is limited to managing symptoms. Further research into new treatment methods for POLR3A-induced leukodystrophy is imperative to improve the quality of life and potentially extend the life expectancy of patients.

show abstract

Section: Case Reportmentioning

confidence: 99%